AddLife originated as an independent life science business division within the Addtech group before being strategically spun off and floated as a separate publicly traded company on Nasdaq Stockholm. The corporate separation was designed to allow AddLife to focus entirely on its core mission of providing high-quality medical technology, diagnostic equipment, and life science consumables to healthcare providers and research institutions across Europe, enabling specialized management growth and independent capital allocation.